If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

BPMC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.42%

Insider Buying (Last 12 Months): $299,900.00

Insider Selling (Last 12 Months): $9,130,878.29

Blueprint Medicines Insider Trading History Chart

Blueprint Medicines Share Price & Price History

^$62.83

▼ -2.17 (-3.34%)

As of 10/6/2022 01:00 AM ET

Days: 30 | 90 | 365

The New King of EVs

From Oxford Club | Ad

This revolutionary car could be the new king of the electric vehicle industry. See the details here.

>>>

Blueprint Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/4/2022	Fouad Namouni	Insider	Sell	3,477	$67.30	$234,002.10	52,797
8/24/2022	Debra Durso-Bumpus	Insider	Sell	5,000	$75.11	$375,550.00	40,836
8/22/2022	Jeffrey W. Albers	Director	Sell	8,410	$70.54	$593,241.40	183,243
8/19/2022	Jeffrey W. Albers	Director	Sell	1,590	$70.02	$111,331.80	183,243
8/16/2022	Jeffrey W. Albers	Director	Sell	20,000	$68.41	$1,368,200.00	183,243
8/8/2022	Jeffrey W. Albers	Director	Sell	10,000	$70.07	$700,700.00	183,243
8/4/2022	Christopher K Murray	SVP	Sell	2,500	$60.44	$151,100.00	21,320
6/6/2022	Percy H. Carter	Insider	Sell	1,908	$59.76	$114,022.08	28,685
4/6/2022	Jeffrey W. Albers	CEO	Sell	5,000	$70.11	$350,550.00	183,243
3/17/2022	George Demetri	Director	Sell	10	$58.56	$585.60	5,812
3/16/2022	L. Becker Hewes	Insider	Sell	2,219	$60.00	$133,140.00
3/10/2022	Ariel Hurley	Insider	Sell	2,339	$57.15	$133,673.85
3/7/2022	Ariel Hurley	Insider	Sell	256	$56.19	$14,384.64
3/3/2022	Ariel Hurley	Insider	Sell	761	$60.27	$45,865.47
3/3/2022	Mark Alan Goldberg	Director	Buy	5,000	$59.98	$299,900.00
12/15/2021	L. Becker Hewes	Insider	Sell	729	$100.00	$72,900.00
12/13/2021	Kate Haviland	COO	Sell	1,000	$98.30	$98,300.00
12/7/2021	Tracey L. Mccain	EVP	Sell	5,000	$97.30	$486,500.00
11/15/2021	Jeffrey W. Albers	CEO	Sell	30,000	$114.50	$3,435,000.00
11/15/2021	L. Becker Hewes	Insider	Sell	729	$115.49	$84,192.21
11/3/2021	Tracey L. Mccain	EVP	Sell	5,000	$110.56	$552,800.00
10/15/2021	L. Becker Hewes	Insider	Sell	729	$102.66	$74,839.14
10/5/2021	Fouad Namouni	Insider	Sell	3,241	$98.18	$318,201.38
9/23/2021	Ariel Hurley	Insider	Sell	600	$110.00	$66,000.00
9/23/2021	Tracey L. Mccain	EVP	Sell	25,000	$108.85	$2,721,250.00
8/19/2021	Jeffrey W. Albers	CEO	Sell	25,000	$92.68	$2,317,000.00
8/17/2021	Ariel Hurley	Insider	Sell	1,350	$91.93	$124,105.50	10,747
6/28/2021	Kate Haviland	COO	Sell	1,000	$90.24	$90,240.00	54,948
5/12/2021	Jeffrey W. Albers	CEO	Sell	25,000	$92.69	$2,317,250.00	179,948
1/4/2021	George Demetri	Director	Sell	758	$112.15	$85,009.70	3,562
12/24/2020	Mark Alan Goldberg	Director	Sell	5,455	$125.00	$681,875.00	9,017
12/17/2020	Charles A. Rowland, Jr.	Director	Sell	10,909	$117.82	$1,285,298.38	14,471
12/1/2020	Mark Alan Goldberg	Director	Sell	5,454	$110.00	$599,940.00	9,016
11/3/2020	Christina Rossi	Insider	Sell	345	$99.69	$34,393.05	20,020
10/16/2020	Kate Haviland	COO	Sell	13,334	$101.23	$1,349,800.82	56,172
10/7/2020	Ariel Hurley	Insider	Sell	600	$100.00	$60,000.00	10,584
10/7/2020	Jeffrey W. Albers	CEO	Sell	5,000	$99.17	$495,850.00	146,434
10/7/2020	Mark Alan Goldberg	Director	Sell	5,454	$100.00	$545,400.00	9,016
9/22/2020	Anthony L Boral	Insider	Sell	6,864	$82.33	$565,113.12	25,828
9/22/2020	George Demetri	Director	Sell	1,704	$85.00	$144,840.00	4,320
9/22/2020	Kate Haviland	COO	Sell	3,143	$85.49	$268,695.07	45,981
9/17/2020	Anthony L Boral	Insider	Sell	23,136	$80.00	$1,850,880.00	28,843
9/17/2020	Nicholas Lydon	Director	Sell	500	$80.00	$40,000.00	47,240
8/17/2020	Ariel Hurley	Insider	Sell	700	$75.00	$52,500.00	10,684
7/6/2020	Nicholas Lydon	Director	Sell	26,007	$80.45	$2,092,263.15	48,340
7/2/2020	Nicholas Lydon	Director	Sell	4,125	$80.16	$330,660.00	76,572
6/22/2020	Nicholas Lydon	Director	Sell	13,017	$80.29	$1,045,134.93	89,039
6/18/2020	Debra Durso-Bumpus	Insider	Sell	2,500	$75.18	$187,950.00	22,005
6/9/2020	Ariel Hurley	Insider	Sell	700	$75.00	$52,500.00	10,684
5/12/2020	Jeffrey W. Albers	CEO	Sell	20,000	$64.67	$1,293,400.00	161,434
3/23/2020	Jeffrey W. Albers	CEO	Sell	20,000	$52.10	$1,042,000.00	141,434
3/23/2020	Marion Dorsch	Insider	Sell	1,214	$52.49	$63,722.86	16,265
1/10/2020	George Demetri	Director	Sell	568	$85.00	$48,280.00	2,462
1/10/2020	Kate Haviland	COO	Sell	7,763	$85.16	$661,097.08	23,628
1/7/2020	George Demetri	Director	Sell	1,705	$80.59	$137,405.95	3,030
12/19/2019	Marion Dorsch	Insider	Sell	4,600	$79.00	$363,400.00	4,600
12/16/2019	Ariel Hurley	Insider	Sell	415	$75.00	$31,125.00	415
12/4/2019	Ariel Hurley	Insider	Sell	192	$77.25	$14,832.00
11/18/2019	Jeffrey W. Albers	CEO	Sell	8,256	$75.42	$622,667.52	66,961
11/8/2019	Jeffrey W. Albers	CEO	Sell	11,744	$74.56	$875,632.64	66,961
10/17/2019	Ariel Hurley	Insider	Sell	415	$75.00	$31,125.00	415

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Blueprint Medicines (NASDAQ:BPMC)

Institutional Buying and Selling by Quarter

Blueprint Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/13/2022	Brown Advisory Inc.	960,269	$48.50M	0.1%	+5.1%	1.612%
8/23/2022	Captrust Financial Advisors	17,074	$0.86M	0.0%	+5.4%	0.029%
8/22/2022	Legal & General Group Plc	54,708	$2.76M	0.0%	+2.5%	0.092%
8/22/2022	ExodusPoint Capital Management LP	16,988	$0.86M	0.0%	N/A	0.029%
8/19/2022	Walleye Capital LLC	5,234	$0.26M	0.0%	N/A	0.009%
8/18/2022	Goldman Sachs Group Inc.	258,144	$13.04M	0.0%	-15.9%	0.433%
8/17/2022	Nomura Holdings Inc.	103,251	$5.15M	0.0%	N/A	0.173%
8/16/2022	Captrust Financial Advisors	17,088	$0.86M	0.0%	+5.4%	0.029%
8/16/2022	Woodline Partners LP	116,087	$5.86M	0.1%	+366.7%	0.195%
8/16/2022	Price T Rowe Associates Inc. MD	5,631,687	$284.46M	0.0%	+14.2%	9.454%
8/16/2022	Prudential Financial Inc.	6,484	$0.34M	0.0%	-89.8%	0.011%
8/16/2022	Casdin Capital LLC	1,150,000	$58.09M	4.9%	-25.8%	1.931%
8/16/2022	DAFNA Capital Management LLC	261,280	$13.20M	3.6%	+6.1%	0.439%
8/15/2022	State Street Corp	2,716,542	$137.21M	0.0%	+19.8%	4.560%
8/15/2022	Macquarie Group Ltd.	1,274,889	$64.39M	0.1%	+3.4%	2.140%
8/15/2022	Capital Impact Advisors LLC	6,005	$0.30M	0.3%	-28.6%	0.010%
8/15/2022	Cubist Systematic Strategies LLC	47,613	$2.41M	0.0%	+51.4%	0.080%
8/15/2022	Point72 Asset Management L.P.	172,482	$8.71M	0.0%	N/A	0.290%
8/15/2022	Nomura Holdings Inc.	103,251	$5.15M	0.0%	N/A	0.173%
8/15/2022	Voya Investment Management LLC	81,155	$4.10M	0.0%	-30.3%	0.136%
8/15/2022	Sei Investments Co.	10,062	$0.51M	0.0%	-56.5%	0.017%
8/15/2022	UBS Asset Management Americas Inc.	280,362	$14.16M	0.0%	+16.8%	0.471%
8/13/2022	Teacher Retirement System of Texas	9,450	$0.48M	0.0%	-18.3%	0.016%
8/13/2022	Virtu Financial LLC	6,646	$0.34M	0.0%	N/A	0.011%
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	7,649	$0.39M	0.0%	-3.2%	0.013%
8/13/2022	American International Group Inc.	27,968	$1.41M	0.0%	-3.7%	0.047%
8/12/2022	Northern Trust Corp	556,462	$28.11M	0.0%	-4.0%	0.934%
8/12/2022	Virtus ETF Advisers LLC	5,089	$0.26M	0.1%	+35.3%	0.009%
8/12/2022	Ensign Peak Advisors Inc	63,198	$3.19M	0.0%	-10.5%	0.106%
8/12/2022	Hudson Bay Capital Management LP	235,900	$11.92M	0.1%	+262.9%	0.396%
8/12/2022	Credit Suisse AG	55,621	$2.81M	0.0%	-3.9%	0.093%
8/12/2022	Fox Run Management L.L.C.	6,082	$0.31M	0.2%	N/A	0.010%
8/12/2022	ClariVest Asset Management LLC	29,946	$1.51M	0.1%	-14.8%	0.050%
8/12/2022	Rafferty Asset Management LLC	79,403	$4.01M	0.0%	-15.2%	0.133%
8/12/2022	FMR LLC	8,576,079	$433.18M	0.0%	+60.8%	14.397%
8/12/2022	BNP Paribas Arbitrage SA	29,668	$1.50M	0.0%	+250.4%	0.050%
8/12/2022	Rhumbline Advisers	72,108	$3.64M	0.0%	+13.7%	0.121%
8/11/2022	AlphaCrest Capital Management LLC	4,883	$0.25M	0.0%	-34.6%	0.008%
8/11/2022	Trexquant Investment LP	5,399	$0.27M	0.0%	N/A	0.009%
8/11/2022	Deutsche Bank AG	194,641	$9.83M	0.0%	-1.7%	0.327%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	685,000	$34.60M	0.2%	N/A	1.150%
8/11/2022	UBS Group AG	33,248	$1.68M	0.0%	-31.2%	0.056%
8/11/2022	Platinum Investment Management Ltd.	40,004	$2.02M	0.1%	+47.5%	0.067%
8/11/2022	JPMorgan Chase & Co.	1,724,490	$87.11M	0.0%	+2.9%	2.895%
8/10/2022	Synovus Financial Corp	29,549	$1.49M	0.0%	+10.6%	0.050%
8/10/2022	Mutual of America Capital Management LLC	40,313	$2.04M	0.0%	-0.7%	0.068%
8/10/2022	Mackenzie Financial Corp	4,235	$0.21M	0.0%	+26.5%	0.007%
8/10/2022	Eagle Asset Management Inc.	189,216	$9.56M	0.1%	-47.0%	0.318%
8/10/2022	California Public Employees Retirement System	111,946	$5.65M	0.0%	-9.7%	0.188%
8/10/2022	Principal Financial Group Inc.	16,032	$0.81M	0.0%	-5.8%	0.027%
8/10/2022	William Blair Investment Management LLC	1,065,128	$53.80M	0.2%	-1.9%	1.788%
8/9/2022	Swiss National Bank	139,500	$7.05M	0.0%	+5.6%	0.234%
8/9/2022	Pictet Asset Management SA	402,742	$20.34M	0.0%	-39.6%	0.676%
8/8/2022	Walleye Capital LLC	5,234	$0.26M	0.0%	N/A	0.009%
8/5/2022	State Board of Administration of Florida Retirement System	22,672	$1.15M	0.0%	-2.7%	0.038%
8/5/2022	Loomis Sayles & Co. L P	329,760	$16.66M	0.0%	-24.7%	0.554%
8/4/2022	Steward Partners Investment Advisory LLC	1,317	$67K	0.0%	+113.5%	0.002%
8/4/2022	Northwestern Mutual Wealth Management Co.	850	$43K	0.0%	+717.3%	0.001%
8/4/2022	EFG Asset Management North America Corp.	130,454	$6.59M	1.4%	-4.6%	0.219%
8/4/2022	TD Asset Management Inc.	96,024	$4.85M	0.0%	-4.9%	0.161%
8/3/2022	Envestnet Asset Management Inc.	13,872	$0.70M	0.0%	+10.2%	0.023%
8/3/2022	Integral Health Asset Management LLC	130,000	$6.57M	1.4%	-15.0%	0.218%
8/3/2022	Nisa Investment Advisors LLC	684	$35K	0.0%	+50.7%	0.001%
8/3/2022	Torray LLC	15,164	$0.77M	0.1%	+21.4%	0.025%
8/3/2022	Candriam S.C.A.	257,172	$12.99M	0.1%	+35.8%	0.432%
8/2/2022	Aigen Investment Management LP	13,284	$0.67M	0.1%	+48.9%	0.022%
8/2/2022	Comerica Bank	126,474	$7.02M	0.1%	+16.0%	0.212%
8/2/2022	Brown Advisory Inc.	959,644	$48.78M	0.1%	+5.1%	1.611%
8/1/2022	NBW Capital LLC	35,945	$1.82M	0.5%	+21.7%	0.060%
8/1/2022	Victory Capital Management Inc.	6,529	$0.33M	0.0%	-9.4%	0.011%
8/1/2022	ProShare Advisors LLC	12,330	$0.62M	0.0%	-33.2%	0.021%
8/1/2022	Profund Advisors LLC	8,077	$0.41M	0.0%	-10.9%	0.014%
7/29/2022	Tekla Capital Management LLC	111,118	$5.61M	0.2%	+14.3%	0.187%
7/29/2022	SG Americas Securities LLC	19,383	$0.98M	0.0%	+6.5%	0.033%
7/29/2022	Russell Investments Group Ltd.	66,216	$3.34M	0.0%	+98.9%	0.111%
7/28/2022	Arizona State Retirement System	16,044	$0.81M	0.0%	+6.2%	0.027%
7/28/2022	Oak Ridge Investments LLC	15,874	$0.80M	0.1%	-7.3%	0.027%
7/27/2022	Bailard Inc.	35,867	$1.81M	0.1%	-56.0%	0.060%
7/27/2022	Assenagon Asset Management S.A.	458,806	$23.17M	0.1%	+67.0%	0.770%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	21,240	$1.07M	0.0%	N/A	0.036%
7/25/2022	Allspring Global Investments Holdings LLC	2,285	$0.12M	0.0%	-91.0%	0.004%
7/25/2022	Strs Ohio	4,000	$0.20M	0.0%	-42.0%	0.007%
7/22/2022	Parametrica Management Ltd	4,918	$0.25M	0.3%	N/A	0.008%
7/20/2022	Peregrine Capital Management LLC	132,621	$6.70M	0.2%	+4.5%	0.223%
7/20/2022	Exchange Traded Concepts LLC	9,348	$0.47M	0.0%	N/A	0.016%
7/15/2022	Mayflower Financial Advisors LLC	6,806	$0.34M	0.1%	-5.5%	0.011%
7/13/2022	EFG Asset Management Americas Corp.	6,687	$0.34M	0.1%	-15.0%	0.011%
6/30/2022	Amalgamated Bank	9,415	$0.60M	0.0%	-7.0%	0.016%
6/7/2022	Bank of America Corp DE	367,091	$23.45M	0.0%	+28.5%	0.616%
5/20/2022	The Manufacturers Life Insurance Company	63,312	$4.09M	0.0%	+114.7%	0.106%
5/18/2022	BNP Paribas Arbitrage SA	8,468	$0.54M	0.0%	-31.5%	0.014%
5/18/2022	Golden State Equity Partners	2,070	$0.20M	0.1%	N/A	0.003%
5/17/2022	Point72 Hong Kong Ltd	3,313	$0.21M	0.0%	N/A	0.006%
5/17/2022	Quantbot Technologies LP	1,500	$95K	0.0%	N/A	0.003%
5/17/2022	Royal Bank of Canada	7,579	$0.48M	0.0%	-57.6%	0.013%
5/17/2022	Rock Springs Capital Management LP	947,715	$60.54M	1.5%	+10.2%	1.591%
5/17/2022	Eaton Vance Management	105,829	$6.76M	0.0%	-59.8%	0.178%
5/17/2022	Eventide Asset Management LLC	592,500	$37.85M	0.6%	+49.7%	0.995%
5/17/2022	Ensign Peak Advisors Inc	70,624	$4.51M	0.0%	+4.1%	0.119%
5/17/2022	Farallon Capital Management LLC	1,356,987	$86.68M	0.5%	+67.2%	2.278%

Data available starting January 2016

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $62.83

$62.76

$65.00

50 Day Range

MA: $68.35

$50.60

$77.70

52 Week Range

Now: $62.83

$43.46

$117.86

Volume

542,833 shs

Average Volume

762,199 shs

Market Capitalization

$3.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.78

Who are the company insiders with the largest holdings of Blueprint Medicines?: Blueprint Medicines' top insider investors include:
Jeffrey W Albers (CEO)
Jeffrey W Albers (Director)
Kate Haviland (COO)
Fouad Namouni (Insider)
Debra Durso-Bumpus (Insider)
Percy H Carter (Insider)
Christopher K Murray (SVP)
Christina Rossi (Insider)
Charles A Rowland Jr (Director)
Ariel Hurley (Insider)
Mark Alan Goldberg (Director)
George Demetri (Director)
L Becker Hewes (Insider)
Tracey L Mccain (EVP)
Learn More about top insider investors at Blueprint Medicines.